What does SanBio Company Limited do?
SanBio Company Limited engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States. It develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury. The company's research pipeline products also comprise…
What is SanBio Company Limited's P/E and P/B ratio?
SanBio Company Limited has a P/E ratio of -19.5 and a P/B ratio of 6.40.
What is SanBio Company Limited's debt-to-equity ratio?
SanBio Company Limited has a debt-to-equity ratio of 0.10.
How much does SanBio Company Limited owe compared with what it owns?
SanBio Company Limited owes ¥0.14 for every ¥1 it owns (balance sheet Jul 2026), which is low.
What is SanBio Company Limited's Positivity rank?
SanBio Company Limited is ranked #7,985 of 10,750 companies globally and #3,356 of 3,683 in Japan on PositoAI, with a Positivity Score of 19,540.
Does SanBio Company Limited have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for SanBio Company Limited.
Where can I read the latest news about SanBio Company Limited?
Recent headlines about SanBio Company Limited from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does SanBio Company Limited have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of SanBio Company Limited's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.